Poniard completes equity-based line of credit

Poniard Pharmaceuticals Inc. (NASDAQ:PARD), South San Francisco, Calif. Business: Cancer Date completed: 3/15/10 Type: Equity-based line of credit Raised: $6.3 million Shares: 4.2 million Price: $1.49...